Observational studies can identify associations between vitamin K status, dietary patterns, biomarkers, and cardiovascular outcomes. However, people who consume more vitamin K-rich foods may also have healthier diets, greater physical activity, different socioeconomic circumstances, or other characteristics that influence cardiovascular risk. Researchers attempt to account for these differences statistically, but residual confounding can remain.

Randomized controlled trials offer a stronger way to assess cause and effect because participants are assigned to an intervention or a comparison group. When properly designed, these trials can help determine whether supplementation produces a measurable difference in a specific outcome. Their conclusions nevertheless depend on sample size, follow-up duration, adherence, study population, and the quality of the methods used.

A systematic review and meta-analysis published in 2023 examined 14 randomized controlled trials involving a total of 1,533 participants. The researchers evaluated vitamin K supplementation in relation to coronary artery calcification, other forms of vascular or valvular calcification, vascular stiffness, and dp-ucMGP.

The analysis reported a statistically significant effect on the progression of coronary artery calcification, with a pooled mean difference of approximately −17.37 in the calcium-score change reported by the included studies. The confidence interval was relatively wide, ranging from approximately −34.18 to −0.56. The researchers also reported a significant reduction in dp-ucMGP.

These findings suggest that vitamin K supplementation may influence certain processes associated with vascular calcification. However, several qualifications are necessary.

First, the analysis included different vitamin K interventions and study populations. The pooled result should not be interpreted as definitive evidence that every form of vitamin K, or vitamin K2 specifically, produces the same benefit.

Second, a statistically significant result does not automatically establish a large or clinically important effect. The magnitude of the difference, its uncertainty, and its relevance to patient outcomes must all be considered.

Third, the review identified limitations in the available evidence and called for more rigorously designed randomized controlled trials. The researchers did not establish that supplementation prevents cardiovascular events or reduces mortality.

Fourth, a calcium score is an intermediate outcome. It can provide important information about calcified plaque, but an intervention that changes the rate of calcium accumulation must still be evaluated to determine whether it improves the outcomes that matter most to patients.

These distinctions are essential when interpreting the results of nutritional research. A promising signal can justify additional investigation without establishing that a supplement should be routinely recommended for disease prevention.

Source: Mott et al. (2023), Vitamin K supplementation and vascular calcification: a systematic review and meta-analysis of randomized controlled trials.

https://pmc.ncbi.nlm.nih.gov/articles/PMC10218696/

6. Coronary Calcification and Aortic Calcification: Why Different Findings Must Be Interpreted Carefully

Some discussions of vitamin K2 suggest that the nutrient may reduce coronary artery calcification while being associated with increased aortic calcification. Such statements require particularly careful examination because they can create the misleading impression that supplementation has a clearly established, contradictory effect on different parts of the cardiovascular system.

To evaluate this possibility, it is necessary to distinguish three different types of findings: an observed association, a difference between treatment groups, and a demonstrated causal effect.

An observational association occurs when two variables appear together more frequently than expected. For example, researchers may find that people with higher concentrations of an inactive form of MGP also have more extensive arterial calcification. Such a finding can help identify biological relationships, but it does not prove that changing the biomarker will necessarily change the disease.

A treatment-group difference is observed when participants assigned to a supplement have a different outcome from participants assigned to a control group. Randomization strengthens the interpretation of this difference, although the study's design and statistical uncertainty still matter.

A causal treatment effect requires evidence that the intervention itself produced the difference rather than the result being explained by chance, bias, confounding, or other factors.

This framework is important when interpreting studies that examine different vascular regions. Coronary artery calcification and aortic calcification may be measured with different techniques, assessed over different periods, or investigated in populations with different underlying diseases. A result in one vascular region cannot be assumed to apply to another.

The available systematic review evidence supports the conclusion that vitamin K supplementation can improve certain biomarkers and may modestly slow coronary artery calcium progression in some settings. It does not establish a general rule that vitamin K2 increases aortic calcification.

If an individual study reports an unexpected finding involving aortic calcification, researchers must consider the sample size, baseline differences, study duration, imaging methods, statistical uncertainty, and whether the result was a prespecified outcome. Replication in independent studies is also important.

A finding that is inconsistent with the proposed biological mechanism should not be dismissed simply because it is unexpected. Equally, it should not be presented as an established adverse effect without adequate evidence. Scientific interpretation requires examining the complete study rather than relying on a single sentence or an isolated statistical result.

There is another important consideration: calcification scores can change for reasons that do not necessarily correspond directly to changes in cardiovascular risk. Calcification is one component of atherosclerotic disease, and the relationship between calcium deposition, plaque stability, plaque composition, and clinical events is complex. A reduction in the progression of one imaging marker does not automatically establish that the entire atherosclerotic process has improved.

For these reasons, claims about opposite effects on coronary and aortic calcification should be supported by clearly identified studies that directly measure both outcomes. Without such evidence, the more responsible conclusion is that the effects of vitamin K2 on different vascular regions remain an area for further investigation.

7. Vitamin K2 and Insulin Resistance: Exploring a Possible Metabolic Connection

In addition to its potential role in vascular calcification, vitamin K has been investigated for possible effects on glucose metabolism and insulin sensitivity. This area of research is relevant because metabolic health and cardiovascular health are closely connected.

Insulin is a hormone produced by the pancreas that helps regulate blood glucose. Following a meal, blood glucose rises as carbohydrates are digested and absorbed. Insulin signals various tissues, including skeletal muscle and adipose tissue, to take up and process nutrients. It also influences glucose production by the liver.

Insulin resistance develops when cells respond less effectively to insulin. The pancreas may initially compensate by producing more insulin, allowing blood glucose to remain within the normal range for a time. As the condition progresses, however, the body's ability to maintain normal glucose regulation may deteriorate.

Prediabetes describes blood glucose levels that are above the normal range but below the diagnostic threshold for diabetes. It indicates an increased risk of developing type 2 diabetes, although progression is not inevitable. Lifestyle interventions and appropriate medical care can substantially influence the likelihood of progression.

Insulin resistance is associated with several factors, including genetics, physical inactivity, excess accumulation of visceral fat, sleep disturbances, certain medications, and other metabolic or hormonal conditions. Its relationship with cardiovascular disease is complex because insulin resistance often occurs alongside high blood pressure, abnormal blood lipids, inflammation, and other risk factors.

Researchers have therefore investigated whether vitamin K might influence insulin sensitivity through effects on vitamin K-dependent proteins or other biological pathways. Some experimental studies have suggested possible links between vitamin K, glucose metabolism, and inflammatory processes. However, findings from laboratory and animal studies cannot automatically be generalized to humans.